1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65FEAE3E1644CC6BA85256EBC006CAEDA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/commercializing-new-products-allocating-resources-and-managing-the-product-life-cycle?opendocument
18
19opendocument
203.95.131.97
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Managing Development Process Development Activities

Commercializing New Products, Allocating Resources, and Managing the Product Life Cycle

DB Image

ID: 5374


Features:

Graphics


Pages/Slides: 18


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • BROWSE SELECTED PAGES
  • SPECIAL OFFER

Study Overview

Top companies find that developing yearly business plans for all products in the development pipeline allow companies to budget all resources, thereby reducing waste and idle resources. This document discusses how to most effectively commercialize new products, allocate the necessary resources, and manage the product life cycle. This document can help companies schedule resource allocations only when developmentally required. This 18-page document shows pharmaceutical companies how to manage cross-functional teams to include and align diverse perspectives in the LCM plan, incorporating representation from clinical/R&D, commercial, marketing, and legal departments.

Key Topics

  • Commercializing New Products
  • Prioritizing Products and Allocating Resources
  • Managing the Product Life Cycle

SAMPLE BEST PRACTICES

  • Identify commercial issues early in the new product planning process to better allocate resources.
    * One benchmark company closely examines the commercial potential of each product in the company’s development portfolio. The company evaluates the commercial potential at numerous points in the development process.
  • Conduct yearly reviews of the product portfolio to ensure promising products receive needed resources.
    * Each year Company A conducts a thorough product portfolio review, including both products in development and those already on the market. In this process, senior executives review information from the product team leaders and then make strategic decisions for every portfolio product.
  • Manage cross-functional teams to include and align diverse perspectives in the LCM plan.

METHODOLOGY

The insights and best practices showcased in this report are distilled from lessons learned in interviews with executives and specialists who have extensive experience in designing and managing new product planning and strategic alliance departments at a range of pharmaceutical companies. This document originated from a Best Practices, LLC consulting project.


Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Eli Lilly; Pfizer; Amgen; Janssen

Browse Selected Pages
Click on an image below to see the full PDF version


Cover Page

Sample Page 1

Sample Page 2

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.